Kalshi has partnered with AppliedXL to launch a pilot suite of prediction markets tied to clinical trial outcomes and FDA regulatory decisions.
Kalshi and AppliedXL have collaborated to introduce a pilot suite of prediction markets focused on clinical trial outcomes and FDA regulatory determinations. This innovative pilot program allows traders to wager on specific drug programs rather than the company's stock performance. The average cost of bringing a single drug to market is approximately $2.3...
